[{"address1": "1-8, Doshomachi 3-chome", "address2": "Chuo-ku", "city": "Osaka", "zip": "541-0045", "country": "Japan", "phone": "81 6 6202 2161", "fax": "81 6 6229 9596", "website": "https://www.shionogi.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.", "fullTimeEmployees": 4955, "companyOfficers": [{"maxAge": 1, "name": "Dr. Isao  Teshirogi Ph.D.", "age": 65, "title": "CEO, President & Representative Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 1867824, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Takeshi  Shiota Ph.D.", "title": "Corporate Officer and Senior VP of Corporate Quality Assurance, Ethics & Compliance Management Div.", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yoshimasa  Kyokawa", "title": "Vice President of Corporate Communications & Secretary Office", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Yoshihiro  Furuya", "title": "Vice President of General Marketing and Compliance Officer of Corporate GXP Compliance Office", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Koji  Hanasaki Ph.D.", "title": "Senior Executive Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John A.  Keller Ph.D.", "age": 59, "title": "Senior Exec. Officer & SVP of R&D Supervisory Unit and Pharma. Tech. Research Div.", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kazuhiro  Hatanaka", "title": "Senior Executive Officer & Senior VP of Corporate Supervisory Unit", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Akira  Kato Ph.D.", "title": "Senior Executive Officer & Senior VP of Supply Supervisory Unit", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Toshinobu  Iwasaki Ph.D.", "title": "Senior Executive Officer & Senior VP of Healthcare Business Supervisory Unit", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Masashi  Deguchi Ph.D.", "title": "Corporate Officer & Senior VP of Sustainability Management Division", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.shionogi.co.jp/ir_en/highlight/index.html", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.59, "open": 7.61, "dayLow": 7.59, "dayHigh": 7.61, "regularMarketPreviousClose": 7.59, "regularMarketOpen": 7.61, "regularMarketDayLow": 7.59, "regularMarketDayHigh": 7.61, "dividendRate": 0.18, "dividendYield": 2.4, "exDividendDate": 1727654400, "payoutRatio": 0.1344, "fiveYearAvgDividendYield": 2.0, "beta": 0.124, "trailingPE": 11.191176, "forwardPE": 3.0809717, "volume": 10210, "regularMarketVolume": 10259, "averageVolume": 88012, "averageVolume10days": 123280, "averageDailyVolume10Day": 123280, "bid": 7.58, "ask": 7.61, "bidSize": 400, "askSize": 400, "marketCap": 12967897088, "fiftyTwoWeekLow": 6.22, "fiftyTwoWeekHigh": 8.72, "priceToSalesTrailing12Months": 0.029586807, "fiftyDayAverage": 7.88128, "twoHundredDayAverage": 7.341985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -345826295808, "profitMargins": 0.38876998, "floatShares": 850251751, "sharesOutstanding": 1701369984, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00011, "impliedSharesOutstanding": 1704060032, "bookValue": 1600.944, "priceToBook": 0.0047534457, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "earningsQuarterlyGrowth": 0.051, "netIncomeToCommon": 170400006144, "trailingEps": 0.68, "forwardEps": 2.47, "lastSplitFactor": "3:2", "lastSplitDate": 1727827200, "enterpriseToRevenue": -0.789, "enterpriseToEbitda": -1.948, "52WeekChange": -0.01039654, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 7.61, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 374799990784, "totalCashPerShare": 440.586, "ebitda": 177570660352, "totalDebt": 21899999232, "quickRatio": 3.828, "currentRatio": 6.634, "totalRevenue": 438299983872, "debtToEquity": 1.607, "revenuePerShare": 257.6155, "returnOnAssets": 0.06631, "returnOnEquity": 0.12963, "grossProfits": 374499999744, "earningsGrowth": 0.056, "revenueGrowth": -0.151, "grossMargins": 0.85444, "ebitdaMargins": 0.40513, "operatingMargins": 0.26145, "financialCurrency": "JPY", "symbol": "SGIOY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchange": "PNK", "messageBoardId": "finmb_875364", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1448980200000, "regularMarketChange": 0.01999998, "regularMarketDayRange": "7.59 - 7.61", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 88012, "fiftyTwoWeekLowChange": 1.3900003, "fiftyTwoWeekLowChangePercent": 0.22347273, "fiftyTwoWeekRange": "6.22 - 8.72", "fiftyTwoWeekHighChange": -1.1100001, "fiftyTwoWeekHighChangePercent": -0.12729359, "fiftyTwoWeekChangePercent": -1.039654, "dividendDate": 1576540800, "earningsTimestamp": 1747031400, "earningsTimestampStart": 1753682400, "earningsTimestampEnd": 1754028000, "earningsCallTimestampStart": 1747047540, "earningsCallTimestampEnd": 1747047540, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.68, "epsForward": 2.47, "fiftyDayAverageChange": -0.2712798, "fiftyDayAverageChangePercent": -0.03442078, "twoHundredDayAverageChange": 0.2680149, "twoHundredDayAverageChangePercent": 0.036504418, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Shionogi & Co. Ltd.", "longName": "Shionogi & Co., Ltd.", "regularMarketChangePercent": 0.26350436, "regularMarketPrice": 7.61, "corporateActions": [], "regularMarketTime": 1747425600, "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]